MINT Conditioning to Improve Gait (NCT07041775) | Clinical Trial Compass
RecruitingNot Applicable
MINT Conditioning to Improve Gait
United States72 participantsStarted 2026-06-04
Plain-language summary
This study will test the ability of myoelectric interface for neurorehabilitation (MINT) training to improve walking function.
Who can participate
Age range
18 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age at enrollment is 18 to 85
* Leg impairment from unilateral stroke at least 6 months prior to screening
* Severe to moderate gait impairment (ambulatory with a maximum walking speed of 0.8 m/s, i.e., half of normal speed)
* Able to stand without assistance
* Clinically observable gait asymmetry
* Abnormal co-activation between adductor magnus and rectus femoris (R greater than or equal to 0.5)
Exclusion Criteria:
* Cognitive impairment with at least moderately impaired attention on digit-span test, or unable to follow instructions of the MINT task
* Visual impairment (such as hemianopia) preventing sufficient perception of the screen to play the games
* Anesthesia or severe neglect in the affected leg, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest) that impairs ability to play the games
* Participation in another study on the affected leg, or any pharmacological study, within 6 weeks of enrollment
* Inability to understand or follow commands in English due to aphasia or other reason that makes it impossible to perform the training
* Diffuse or multifocal infarcts
* Substantial leg or other pain preventing participation for 60 minutes a day
* Spasticity treatment (pharmacological or Botox) on the affected leg within past 3 months
* Severe osteoporosis causing hip or other fractures
* History of multiple falls within the last year, use of walker for balance, or falling during stance while in the lab in t…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.